- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Lenalidomide – July 2016
Lenalidomide: 5 mg capsule, 21, 10 mg capsule, 21, 15 mg capsule, 21, 25 mg capsule, 21, Revlemid®
Last updated
11 November 2016